Table 3.

Treatment delivery and efficacy

500 mg/m2 (n = 13)375 mg/m2 (n = 3)250 mg/m2 (n = 3)
Doses of cetuximab, median (range)4 (2–15)5 (4–6)6 (4–6)
Patients requiring dose reductions, n (%)4 (31)3 (100)0
Patients requiring dose delay, n (%)4 (31)3 (100)1 (33)
Best response (RECIST)
 Partial response000
 Stable disease1133
 Progression of disease200